Published in Brain Behav on May 01, 2012
Can BACE1 inhibition mitigate early axonal pathology in neurological diseases? J Alzheimers Dis (2014) 0.80
Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. J Neurochem (2015) 0.79
Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons. Mol Brain (2015) 0.78
LRP1 Downregulates the Alzheimer's β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking(1,2,3). eNeuro (2015) 0.78
Progress toward Understanding Protein S-acylation: Prospective in Plants. Front Plant Sci (2017) 0.75
Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer's Disease Model Mice Targeting Beta-Amyloid Production. Front Pharmacol (2017) 0.75
Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease. Acta Biochim Biophys Sin (Shanghai) (2013) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem (1991) 12.68
Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res (1993) 9.81
An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science (1994) 5.10
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol (2003) 4.71
Control of peripheral nerve myelination by the beta-secretase BACE1. Science (2006) 4.55
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci (2006) 3.85
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A (2001) 2.87
Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem (2004) 2.85
Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev (2010) 2.64
BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol (2007) 2.18
beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J Biol Chem (2005) 2.15
Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis (2002) 2.14
Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science (1992) 2.12
Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J Biol Chem (2001) 2.11
The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem (2005) 2.08
Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci U S A (2003) 2.03
Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med (2004) 2.02
The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem (2003) 1.99
Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J Biol Chem (1988) 1.82
Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol (2001) 1.78
BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci U S A (2000) 1.64
Plasma membrane microdomains: organization, function and trafficking. Mol Membr Biol (2004) 1.48
Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge. Trends Pharmacol Sci (2004) 1.41
Palmitoylation of membrane proteins (Review). Mol Membr Biol (2008) 1.37
Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim Biophys Acta (2010) 1.37
Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur J Neurosci (2006) 1.36
Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J Biol Chem (2008) 1.34
The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol (2006) 1.26
Association of active gamma-secretase complex with lipid rafts. J Lipid Res (2005) 1.24
Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimers Dis (2010) 1.17
Active gamma-secretase is localized to detergent-resistant membranes in human brain. FEBS J (2008) 1.13
Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. FASEB J (2007) 1.12
Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation. EMBO Mol Med (2011) 1.11
Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. J Biol Chem (2004) 1.05
Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. J Neurosci Res (2010) 0.98
Understanding BACE1: essential protease for amyloid-beta production in Alzheimer's disease. Cell Mol Life Sci (2008) 0.96
Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity. Biochem Biophys Res Commun (1993) 0.93
Characterization of the ectodomain shedding of the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). J Biol Chem (2003) 0.93
Human BACE forms dimers and colocalizes with APP. J Biol Chem (2004) 0.92
Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci (2004) 0.92
Extracellular release of BACE1 holoproteins from human neuronal cells. Biochem Biophys Res Commun (2005) 0.89
Loss of cleavage at β'-site contributes to apparent increase in β-amyloid peptide (Aβ) secretion by β-secretase (BACE1)-glycosylphosphatidylinositol (GPI) processing of amyloid precursor protein. J Biol Chem (2011) 0.88
Detecting radiolabeled lipid-modified proteins in polyacrylamide gels. Methods Enzymol (1995) 0.88
Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons. J Neurochem (2001) 0.84
Protein lipidation of BACE. Biochem Soc Trans (2005) 0.79
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol (2008) 3.13
Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med (2012) 2.80
Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci (2005) 2.48
Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet (2009) 2.23
Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model. Neurobiol Aging (2013) 1.46
Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc Natl Acad Sci U S A (2008) 1.36
Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur J Neurosci (2006) 1.36
CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One (2010) 1.34
Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family. FEBS Lett (2006) 1.28
Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides. Biochem J (2007) 1.24
Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J Biol Chem (2007) 1.24
Sodium channel beta4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice. J Neurochem (2006) 1.18
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett (2009) 1.17
Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J Neurochem (2005) 1.16
Single lymphocyte analysis with a microwell array chip. Cytometry A (2007) 1.12
BACE1 modulates filopodia-like protrusions induced by sodium channel beta4 subunit. Biochem Biophys Res Commun (2007) 1.08
Impaired Ca2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice. J Biol Chem (2004) 1.05
Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology (2010) 1.04
Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem (2002) 1.04
A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res (2012) 1.02
Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo. J Biol Chem (2007) 1.01
Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. J Neurosci Res (2010) 0.98
Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease. J Neurosci Res (2005) 0.96
Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain. Acta Neuropathol Commun (2013) 0.95
Biological significance of protein modifications in aging and calorie restriction. Ann N Y Acad Sci (2010) 0.94
Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neurosci Res (2005) 0.93
Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. FASEB J (2004) 0.93
Diphenylarsinic acid poisoning from chemical weapons in Kamisu, Japan. Ann Neurol (2004) 0.92
Drug interaction of tizanidine and ciprofloxacin: case report. Clin Pharmacol Ther (2006) 0.92
MRI of idiopathic lumbosacral plexopathy. Neurology (2004) 0.92
Altered localization of amyloid precursor protein under endoplasmic reticulum stress. Biochem Biophys Res Commun (2006) 0.92
Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci (2004) 0.92
Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples. J Proteome Res (2012) 0.91
Abeta 11-40/42 production without gamma-secretase epsilon-site cleavage. Biochem Biophys Res Commun (2006) 0.91
Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol (2009) 0.91
Protective effect of IL-18 on kainate- and IL-1 beta-induced cerebellar ataxia in mice. J Immunol (2008) 0.91
Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro. Neurosci Lett (2008) 0.91
Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease. FASEB J (2004) 0.90
Autoreactive-Aβ antibodies promote APP β-secretase processing. J Neurochem (2012) 0.89
Extracellular release of BACE1 holoproteins from human neuronal cells. Biochem Biophys Res Commun (2005) 0.89
Molecular dissection of TDP-43 proteinopathies. J Mol Neurosci (2011) 0.89
Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation. Hum Mol Genet (2013) 0.89
Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain (2012) 0.89
Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? FEBS Lett (2007) 0.89
The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J Exp Med (2011) 0.88
A novel mechanism of keratin cytoskeleton organization through casein kinase Iα and FAM83H in colorectal cancer. J Cell Sci (2013) 0.88
Occam's Razor or Hickam's dictum: a paraneoplastic or coincidental occurrence of lung cancer and Guillain-Barré syndrome. Intern Med (2014) 0.88
Recurrent isolated abducens nerve paresis associated with persistent trigeminal artery variant. Intern Med (2012) 0.87
A patient with severe renal amyloidosis associated with an immunoglobulin gamma-heavy chain fragment. Am J Kidney Dis (2004) 0.87
Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl (2008) 0.87
Human CRB2 inhibits gamma-secretase cleavage of amyloid precursor protein by binding to the presenilin complex. J Biol Chem (2010) 0.87
Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor. J Biol Chem (2009) 0.87
Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology. Curr Alzheimer Res (2015) 0.86
IGF-1 promotes beta-amyloid production by a secretase-independent mechanism. Biochem Biophys Res Commun (2009) 0.86
Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid (2005) 0.85
Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Chin Med J (Engl) (2006) 0.85
Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type. J Neurosci Res (2007) 0.85
Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure. J Med Chem (2012) 0.84
In-depth membrane proteomic study of breast cancer tissues for the generation of a chromosome-based protein list. J Proteome Res (2012) 0.84
A Japanese case of fragile-X-associated tremor/ataxia syndrome (FXTAS). Intern Med (2010) 0.84
Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice. Neuropathology (2011) 0.83
Parkinsonism with organophosphate poisoning. BMJ Case Rep (2009) 0.83
Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res (2002) 0.83
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: a vestibular balance control mechanism via the lower brainstem paramedian tract neurons. J Neurol Sci (2013) 0.83
The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1. J Neurosci Res (2009) 0.82
Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans. Neurosci Lett (2003) 0.81
A novel monoclonal antibody specific for the amino-truncated beta-amyloid Abeta5-40/42 produced from caspase-cleaved amyloid precursor protein. J Neurosci Methods (2007) 0.81
Effects of gait rehabilitation with a footpad-type locomotion interface in patients with chronic post-stroke hemiparesis: a pilot study. Clin Rehabil (2012) 0.81
Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice. PLoS One (2012) 0.81
Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Hum Pathol (2010) 0.81
[Case report; a case of anti-glutamate receptor antibody positive limbic encephalitis with positive various autoantibodies]. Nihon Naika Gakkai Zasshi (2013) 0.81
Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice. Curr Alzheimer Res (2013) 0.81
LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains. Orphanet J Rare Dis (2014) 0.81
Mutant presenilin (A260V) affects Rab8 in PC12D cell. Neurochem Int (2004) 0.81
Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau. Acta Neuropathol (2015) 0.80
Magnetic resonance images of herpes zoster myelitis presenting with Brown-Séquard syndrome. Arch Neurol (2010) 0.80
AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report. Amyloid (2008) 0.80
Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons. Neurochem Res (2012) 0.80
Downbeat nystagmus due to a paramedian medullary lesion. J Clin Neurosci (2012) 0.79
Reconstitution of gamma-secretase by truncated presenilin (PS) fragments revealed that PS C-terminal transmembrane domain is critical for formation of gamma-secretase complex. Genes Cells (2006) 0.79
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient. BMJ Case Rep (2012) 0.79
A Japanese case with Nasu-Hakola disease of DAP12 gene mutation exhibiting precuneus hypoperfusion. Intern Med (2011) 0.79
An E3 ubiquitin ligase, Synoviolin, is involved in the degradation of immature nicastrin, and regulates the production of amyloid beta-protein. FEBS J (2009) 0.79
A family of membrane proteins associated with presenilin expression and gamma-secretase function. FASEB J (2007) 0.79